Neuromuscular block: atracurium and vecuronium compared and combined. 1985

T E Black, and T E Healy, and N D Pugh, and B Kay, and N J Harper, and H V Petts, and T Sivalingham

The neuromuscular blocking action of atracurium and vecuronium acting separately and in combination have been compared using the evoked EMG of the adductor pollicis muscle. Dose response curves have been drawn for the drugs given separately and found to be nonparallel (P less than 0.05). Atracurium was calculated to be 5.25 and 4.1 times less potent than vecuronium, ED50 and ED95 respectively. The effect on neuromuscular transmission of a combined medication using equipotent doses of atracurium and vecuronium, determined from the dose response plots, was found to be greater than would be expected by addition of their separate actions. The combination of small doses resulted in significant neuromuscular blockade.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D009466 Neuromuscular Blocking Agents Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. Neuromuscular Blocker,Neuromuscular Blocking Agent,Neuromuscular Blockers,Agent, Neuromuscular Blocking,Agents, Neuromuscular Blocking,Blocker, Neuromuscular,Blockers, Neuromuscular,Blocking Agent, Neuromuscular,Blocking Agents, Neuromuscular
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D010197 Pancuronium A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release. Pancuronium Bromide,Pancuronium Curamed,Pancuronium Organon,Pavulon,Bromide, Pancuronium
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000768 Anesthesia, General Procedure in which patients are induced into an unconscious state through use of various medications so that they do not feel pain during surgery. Anesthesias, General,General Anesthesia,General Anesthesias

Related Publications

T E Black, and T E Healy, and N D Pugh, and B Kay, and N J Harper, and H V Petts, and T Sivalingham
June 1989, British journal of anaesthesia,
T E Black, and T E Healy, and N D Pugh, and B Kay, and N J Harper, and H V Petts, and T Sivalingham
November 1993, British journal of anaesthesia,
T E Black, and T E Healy, and N D Pugh, and B Kay, and N J Harper, and H V Petts, and T Sivalingham
June 1991, British journal of anaesthesia,
T E Black, and T E Healy, and N D Pugh, and B Kay, and N J Harper, and H V Petts, and T Sivalingham
September 1984, Drug intelligence & clinical pharmacy,
T E Black, and T E Healy, and N D Pugh, and B Kay, and N J Harper, and H V Petts, and T Sivalingham
May 1992, British journal of anaesthesia,
T E Black, and T E Healy, and N D Pugh, and B Kay, and N J Harper, and H V Petts, and T Sivalingham
December 1995, Journal of clinical anesthesia,
T E Black, and T E Healy, and N D Pugh, and B Kay, and N J Harper, and H V Petts, and T Sivalingham
March 1993, Anaesthesia,
T E Black, and T E Healy, and N D Pugh, and B Kay, and N J Harper, and H V Petts, and T Sivalingham
August 1987, Anesthesiology,
T E Black, and T E Healy, and N D Pugh, and B Kay, and N J Harper, and H V Petts, and T Sivalingham
August 1988, Anesthesiology,
T E Black, and T E Healy, and N D Pugh, and B Kay, and N J Harper, and H V Petts, and T Sivalingham
October 1983, British journal of anaesthesia,
Copied contents to your clipboard!